Managig Director
Physiolution
Wroclaw, Dolnoslaskie, Poland
Grzegorz Garbacz, PhD, MBA; studied Pharmacy at the Medical University of Wroclaw (1999–2004) and earned his Ph.D. (2010) and habilitation (2020) in Pharmaceutical Sciences. He began his research in 2004 at the University of Greifswald, focusing on biorelevant test models for GI tract simulation. He co-founded Physiolution GmbH (2009) and Physiolution Polska (2017), where he serves as CEO. His research includes GI transit simulation, bio-predictive dissolution testing, solid-state analysis, and innovative drug development.
Disclosure information not submitted.
Predict the Unpredictable - Physiology Driven Testing of Oral Dosages
Monday, July 14, 2025
4:00 PM - 4:20 PM EDT
Predicting Drug Delivery of Push Pull OROS: A Biorelevant Dissolution and PK Simulation Strategy
Thursday, July 17, 2025
11:16 AM - 11:27 AM EDT
